Wanbangde Pharmaceutical Holding Group Co Ltd Asset Resilience Ratio

Latest as of June 2025: 0.24%

Wanbangde Pharmaceutical Holding Group Co Ltd asset resilience ratio. Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has an Asset Resilience Ratio of 0.24% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002082 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥10.41 Million
≈ $1.52 Million USD Cash + Short-term Investments

Total Assets

CN¥4.43 Billion
≈ $647.96 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Wanbangde Pharmaceutical Holding Group Co Ltd (2004–2024)

Asset resilience ratio of Wanbangde Pharmaceutical Holding Group Co Ltd from 2004 to 2024. This chart shows how Wanbangde Pharmaceutical Holding Group Co Ltd's Asset Resilience Ratio has changed over time. Read Wanbangde Pharmaceutical Holding Group C total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Wanbangde Pharmaceutical Holding Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Wanbangde Pharmaceutical Holding Group C total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥10.41 Million 0.24%
Total Liquid Assets CN¥10.41 Million 0.24%

Asset Resilience Insights

  • Limited Liquidity: Wanbangde Pharmaceutical Holding Group Co Ltd maintains only 0.24% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Wanbangde Pharmaceutical Holding Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Wanbangde Pharmaceutical Holding Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Sandoz Group AG
SW:SDZ
Drug Manufacturers - Specialty & Generic 7.89%
H Lundbeck A/S
CO:HLUN-B
Drug Manufacturers - Specialty & Generic -0.56%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 47.16%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Viyash Scientific Limited
NSE:SEQUENT
Drug Manufacturers - Specialty & Generic 0.08%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%

Wanbangde Pharmaceutical Holding Group Co Ltd Asset Resilience Ratio by Year (2004–2024)

Wanbangde Pharmaceutical Holding Group Co Ltd asset resilience ratio by year from 2004 to 2024. The table below shows the annual Asset Resilience Ratio data for Wanbangde Pharmaceutical Holding Group Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.26% CN¥11.15 Million
≈ $1.63 Million
CN¥4.33 Billion
≈ $633.23 Million
-1.74pp
2014-12-31 2.00% CN¥31.00 Million
≈ $4.54 Million
CN¥1.55 Billion
≈ $226.96 Million
+1.92pp
2005-12-31 0.07% CN¥491.18K
≈ $71.88K
CN¥661.73 Million
≈ $96.83 Million
-0.05pp
2004-12-31 0.12% CN¥517.57K
≈ $75.74K
CN¥416.66 Million
≈ $60.97 Million
--
pp = percentage points

About Wanbangde Pharmaceutical Holding Group Co Ltd

SHE:002082 China Drug Manufacturers - Specialty & Generic
Market Cap
$867.35 Million
CN¥5.93 Billion CNY
Market Cap Rank
#9228 Global
#2244 in China
Share Price
CN¥9.69
Change (1 day)
+0.83%
52-Week Range
CN¥8.94 - CN¥36.24
All Time High
CN¥36.24
About

Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascul… Read more